Mid America Heart Institute
The Health Economics Technology Assessment Group (HETA), an independent functional unit within the Mid America Heart Institute (MAHI) will serve as the Health Economic Core Laboratory for the C-TRACT Trial. Its leaders have tremendous experience in performing health economic evaluations in randomized trials of cardiovascular interventions. HETA-MAHI serves as the Economics and Quality of Life Coordinating Center for 4 other NHLBI-funded randomized trials: the FREEDOM Trial (2400 patients, 5-years, coronary artery bypass graft surgery vs. percutaneous coronary intervention); the CORAL Trial (1080 patients, 5-years, renal artery stenting vs. medical therapy for renal artery stenosis); and the CREST Trial (2400 patients, 4-years, carotid artery stenting vs. carotid endarterectomy for symptomatic carotid artery stenosis), and the ATTRACT Trial (692 patients, 7 years, evaluated pharmacomechanical catheter-directed thrombolysis for acute proximal DVT).
In C-TRACT, MAHI will coordinate the collection of economic data on study participants to estimate the costs of the two treatment strategies.